A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity ...

The National Institutes of Health has provided $3.5 million for a large-scale clinical trial testing a radical new approach to managing type 2 diabetes that, in an earlier study, put almost 70% of ...

UCSF research led to the first type 1 diabetes immunotherapy. Now, scientists are using stem cells and Tregs to find a ...

Patients who undergo stepwise escalation often reach treatment failure more often.” He noted that combination therapy may be ...

INDIANAPOLIS — A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of Type 1 diabetes by targeting an ...

The QBSAFE agenda-setting kit (ASK) is a novel patient-centric approach to diabetes care that has feasible study procedures and is well accepted by patients with type 2 diabetes and their clinicians.